| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.006 | 0.9 |